A ground-breaking new trial at Imperial College London sees, for the first time ever under controlled conditions, a psychedelic drug tested head-to-head against a standard antidepressant as a treatment for depression. The film follows a pioneering team of scientists and psychotherapists as they compare the effects of psilocybin (the active ingredient of magic mushrooms) with an antidepressant on a small group of participants with clinical depression.
This is scientific research at its most cutting edge. With over seven million people being prescribed antidepressants each year in England alone, this drug trial is an important milestone in understanding a completely different treatment for depression. How do psychedelic drugs measure up against the industry-standard antidepressants that have been popular since the 1990s? The empirical results of the trial are explored alongside the participants’ powerful lived experience.

Modern headlines are claiming mindfulness may cure anxiety, depression, and a whole host of other health problems. How can this simple practice of watching your own breath change the way your brain works? And can that change your life? The fourth episode of the series looks at the power of mindfulness and meditation. It examines different kinds on meditation (transcendental, dynamic, and religious) and notes that they are different from mindfulness meditation (Satipatthana). Also it talks to neuroscientists who discuss what happens in the brain during meditation.

Mixing comedy with a thorough investigation of psychedelics, the film explores the pros, cons, science, history, future, pop cultural impact, and cosmic possibilities of hallucinogens. The documentary features comedic tripping stories from A-list actors, comedians, and musicians. Star-studded reenactments and trippy animations bring their surreal hallucinations to life.
'Have a Good Trip' tackles the big questions: Can psychedelics have a powerful role in treating depression, addiction, and helping us confront our own mortality? Are we all made of the same stuff? Is love really all we need? Can trees talk?

the rise and fall of a tech industry prodigy. Interviews with his friends and loved ones paint a portrait of Swartz as a martyr of freedom of information and hail his fight for the public's right to access tax-funded academic and scientific research, culminating in a personally devastating two-year Federal lawsuit." An avid researcher who had previously accessed otherwise private databases, Swartz, acting "in the grand tradition of civil disobedience to declare... opposition to this private theft of public culture" used MIT computers to access tax-funded research that would otherwise be held privately by for-profit publishers, an incident many viewers may remember from national headlines just a few year ago. Though neither MIT nor the digital repository Swartz accessed pressed charges, a US Attorney stepped in and filed a 13-count felony charge against Swartz, threatening him with over $1 million in fines and up to 35 years of jail time. Despite the defense of his peers, these events launched Swartz into a two-year long downward spiral of withdrawal and depression. Aaron Swartz's untimely death at the age of 26.

Placebos come in all shapes and sizes, but they contain no active ingredient. They are the miracle pills that shouldn't really work at all. Now they are being shown to help treat pain, depression and even alleviate some of the symptoms of Parkinson's disease. It seems they're not acting alone. The placebo effect is intertwined with how is did the healthcare. Explores why they work, and how we could all benefit from the hidden power of the placebo.

The final episode of this series looks at what happens to the brain when someone uses psychedelic drugs. It looks at how psychedelic drugs may be useful in dealing with anxiety in cancer survivors and serious depression. It explores the history of psychedelics and examines early medical experimentation with the drug. It also discussed why psychedelics were banned and examines how they affect the brain.